Spots Global Cancer Trial Database for randomised
Every month we try and update this database with for randomised cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) | NCT04964934 | ER-Positive HER... | AZD9833 AZD9833 Placebo Anastrozole Anastrozole pla... Letrozole Letrozole place... Palbociclib Abemaciclib Luteinizing hor... Ribociclib | 18 Years - 130 Years | AstraZeneca | |
| A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease | NCT04711252 | ER-Positive HER... | AZD9833 Anastrozole Anastrozole pla... AZD9833 placebo Palbociclib Luteinizing hor... | 18 Years - 130 Years | AstraZeneca | |
| Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging | NCT06276465 | Prostatic Cance... | Darolutamide 30... Stereotactic bo... Androgen depriv... | 18 Years - | UNICANCER | |
| Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | NCT01650428 | Rectal Cancer | Bevacizumab Irinotecan Oxaliplatin 5-Fluorouracil | 18 Years - 75 Years | University College, London | |
| RAW Study Version 3.4 | NCT00280722 | Cancer | patient informa... | 18 Years - | Oxford University Hospitals NHS Trust | |
| RAW Study Version 3.4 | NCT00280722 | Cancer | patient informa... | 18 Years - | Oxford University Hospitals NHS Trust | |
| Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer | NCT02417662 | Non-small Cell ... | Radical Radioth... Non-investigati... | 18 Years - | University College, London | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| RAW Study Version 3.4 | NCT00280722 | Cancer | patient informa... | 18 Years - | Oxford University Hospitals NHS Trust | |
| Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) | NCT04964934 | ER-Positive HER... | AZD9833 AZD9833 Placebo Anastrozole Anastrozole pla... Letrozole Letrozole place... Palbociclib Abemaciclib Luteinizing hor... Ribociclib | 18 Years - 130 Years | AstraZeneca | |
| The LYSA (Linking You to Support and Advice) Trial | NCT05035173 | Survivorship Breast Cancer Cervical Cancer Endometrial Can... | Survivorship Cl... Survivorship Cl... Survivorship Cl... | 18 Years - | University College Cork | |
| Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | NCT01650428 | Rectal Cancer | Bevacizumab Irinotecan Oxaliplatin 5-Fluorouracil | 18 Years - 75 Years | University College, London | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust | |
| Niraparib Efficacy in Patient With Unresectable Mesothelioma | NCT05455424 | Mesothelioma, M... | Niraparib Oral ... Active Symptom ... | 18 Years - | University Hospital Southampton NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
